Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tecnoss Dental is an innovative Italian biotechnology company focused on the research and production of advanced biomaterials for bone and tissue regeneration. Established in 1996, the company developed a unique Dual-Phase technology that allows for the production of heterologous bone grafts that preserve the natural collagen matrix, ensuring high biocompatibility and predictable remodeling. Its flagship brand, OsteoBiol, offers a diverse portfolio of products including bone substitutes, collagen membranes, and specialized gels for dental and maxillofacial applications. These products are widely utilized in procedures such as sinus lifts, ridge augmentations, and periodontal treatments. Tecnoss maintains a strong commitment to scientific excellence, with its materials supported by hundreds of independent clinical studies. The company operates a state-of-the-art manufacturing facility in Italy and distributes its regenerative solutions to clinicians worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tecnoss Dental.